FACILITIES

Our API & Formulation manufacturing facilities strictly adhere to global quality standards.

Our infrastructure capability allows us the flexibility to manufacture large volume APIs for various markets as well as specific molecules for individual customers. Our facilities offer advantages of proximity to a well-established Special Economic Zones (SEZ) with significant common services.

Our Turkish EU GMP compliant formulation facility strictly adheres to global regulatory and safety standards. The facility can handle a range of formulations including injectable suspensions, granules for injections, oral solutions/suspension, aerosol and pour-on/spot-on.

Sequent's manufacturing Infrastructure has enough room to enhance capacities, which will enable us to scale up the production, while reducing time to market.

Our world-class facilities:

Human Health

Mangalore, Karnataka, India

  • Niche Human APIs, Large volume APIs, Advanced Drug Intermediates
  • Best-in-class manufacturing capabilities for large and small molecules with R&D Centre
  • TGA, USFDA, EU, ISO 14001, WHO PQ approved

Mysore, Karnataka, India

  • Large volume APIs, Key drug intermediates for human APIs
    (large volume hydrogenation)
  • cGMP compliant

Mahad, Maharashtra, India

  • Human Health & Animal Health APIs
  • Largest Albendazole manufacturing facility globally
  • EU, cGMP compliant

Alivira Animal Health

Vizag, Andhra Pradesh, India

  • Animal Health APIs
  • Largest integrated veterinary API manufacturing facility in India
  • EU and US filings under progress

Ankara, Turkey

  • Animal Health Formulations
  • Strong focus on injectables
  • EU-GMP compliant

Ambernath, Maharashtra, India

  • Animal Health Formulations
  • cGMP approved

Analytical Solutions (Sequent Research Limited)

Mangalore, Karnataka, India

  • GLP compliant facility Certified & approved
  • ISO 17025, ISO 9001:2008, ISO 14001:2004,TGA, USFDA, WHO.